George Schoen Speaks at the 2022 IBA European Corporate and Private M&A Conference
April 12, 2022
On April 12, 2022, Cravath partner George F. Schoen participated in the 10th annual European Corporate and Private M&A conference, which was hosted by the International Bar Association from April 11‑12, 2022 in Paris. Entitled “With All the Bells and Whistles – Whistleblowing and the M&A Process,” George’s session reviewed the European Union’s new Whistleblower Directive, which applies to both EU and non‑EU companies and has the potential to significantly impact an M&A process. The panel discussed how M&A practitioners can navigate whistleblowing, including how to disclose internal investigations during the due diligence process and protect legal privilege.
Related Practices & Industries
Speakers
- Photo
-
-
J.D., 1998, University of Chicago Law Schoolwith Honors
-
B.A., 1994, Cornell University
- New York
Education
Admitted In
Related News & Insights
Deals & Cases
March 02, 2022
Southwest Gas’s Decision to Separate Centuri
On March 1, 2022, Southwest Gas Holdings, Inc. (“Southwest Gas”) announced that its Board of Directors has unanimously decided to separate its wholly‑owned subsidiary, Centuri Group, Inc. (“Centuri”), from Southwest Gas. The separation is expected to occur within the next 9 to 12 months. As a standalone, independent company, Centuri, an unregulated utility services platform diversified across the U.S. and Canada, will be an industry leader at the forefront of infrastructure modernization. The separation will transform Southwest Gas into a fully regulated natural gas business. Cravath is representing Southwest Gas in connection with the decision to separate Centuri.
Deals & Cases
March 01, 2022
Martin Marietta’s Sale of Certain West Coast Cement and Ready Mixed Concrete Operations to CalPortland Company
On March 1, 2022, Martin Marietta Materials, Inc. (“Martin Marietta”) announced that it has entered into a definitive agreement to sell certain West Coast cement and ready mixed concrete operations to CalPortland Company for $250 million in cash. The operations include the Redding cement plant, related cement distribution terminals and 14 ready mixed concrete plants located in California. Cravath is representing Martin Marietta in connection with the transaction.
Deals & Cases
January 21, 2022
IBM’s Sale of Healthcare Data and Analytics Assets to Francisco Partners
On January 21, 2022, IBM and Francisco Partners, a global investment firm that specializes in partnering with technology businesses, announced that the companies have signed a definitive agreement under which Francisco Partners will acquire healthcare and data analytics assets from IBM that are currently part of the Watson Health business. The assets acquired by Francisco Partners include extensive and diverse data sets and products, including Health Insights, MarketScan, Clinical Development, Social Program Management, Micromedex, and imaging software offerings. Cravath is representing IBM in connection with the transaction.
Deals & Cases
November 12, 2021
Johnson & Johnson’s Planned Separation of its Consumer Health Business
On November 12, 2021, Johnson & Johnson announced its intent to separate its Consumer Health business, creating a new publicly traded company. Following the planned separation, Johnson & Johnson would remain the world’s largest and most diverse healthcare company, with a portfolio that blends its Pharmaceutical and Medical Device capabilities. The New Consumer Health Company would be a leading global consumer health company with iconic brands such as Neutrogena, AVEENO®, Tylenol®, Listerine®, JOHNSON’s®, and BAND‑AID®. Cravath is representing Johnson & Johnson in connection with the planned transaction.
